Related Experiment Video
Updated: Apr 7, 2026

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
Published on: October 9, 2016
Impact of the N-Terminal Domain of STAT3 in STAT3-Dependent Transcriptional Activity
Tiancen Hu1, Jennifer E Yeh2, Luca Pinello3
1Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA Postdoctoral Program, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
Abstract:
The transcription factor STAT3 is constitutively active in many cancers, where it mediates important biological effects, including cell proliferation, differentiation, survival, and angiogenesis. The N-terminal domain (NTD) of STAT3 performs multiple functions, such as cooperative DNA binding, nuclear translocation, and protein-protein interactions. However, it is unclear which subsets of STAT3 target genes depend on the NTD for transcriptional regulation. To identify such genes, we compared gene expression in STAT3-null mouse embryonic fibroblasts (MEFs) stably expressing wild-type STAT3 or STAT3 from which NTD was deleted. NTD deletion reduced the cytokine-induced expression of specific STAT3 target genes by decreasing STAT3 binding to their regulatory regions. To better understand the potential mechanisms of this effect, we determined the crystal structure of the STAT3 NTD and identified a dimer interface responsible for cooperative DNA binding in vitro. We also observed an Ni(2+)-mediated oligomer with an as yet unknown biological function. Mutations on both dimer and Ni(2+)-mediated interfaces affected the cytokine induction of STAT3 target genes. These studies shed light on the role of the NTD in transcriptional regulation by STAT3 and provide a structural template with which to design STAT3 NTD inhibitors with potential therapeutic value.
Insights
The STAT3 N-terminal domain (NTD) is crucial for regulating specific cancer-related genes by influencing STAT3 binding to DNA. Understanding this NTD function offers potential for developing new STAT3 inhibitors.
Area of Science:
- Molecular Biology
- Structural Biology
- Cancer Biology
Background:
- Signal transducer and activator of transcription 3 (STAT3) is constitutively active in numerous cancers.
- STAT3 regulates key cellular processes like proliferation, survival, and angiogenesis.
- The STAT3 N-terminal domain (NTD) is involved in DNA binding, nuclear translocation, and protein interactions, but its specific role in target gene regulation is unclear.
Purpose of the Study:
- To identify STAT3 target genes regulated by the NTD.
- To elucidate the structural mechanisms underlying NTD-mediated transcriptional regulation.
- To provide a structural basis for designing STAT3 NTD inhibitors.
Main Methods:
- Gene expression analysis in STAT3-null mouse embryonic fibroblasts (MEFs) expressing wild-type STAT3 or NTD-deleted STAT3.
- Determination of the STAT3 NTD crystal structure.
- In vitro analysis of STAT3 NTD dimerization and Ni(2+)-mediated oligomerization.
- Site-directed mutagenesis of identified NTD interfaces.
Main Results:
- NTD deletion decreased cytokine-induced expression of specific STAT3 target genes.
- Reduced STAT3 binding to regulatory regions was observed upon NTD deletion.
- Crystal structure revealed a dimer interface critical for cooperative DNA binding and an Ni(2+)-mediated oligomer.
- Mutations in NTD interfaces affected STAT3 target gene induction.
Conclusions:
- The STAT3 NTD plays a significant role in the transcriptional regulation of specific target genes.
- The NTD facilitates STAT3 binding to DNA, influencing gene expression.
- Structural insights into the STAT3 NTD provide a foundation for developing targeted cancer therapies.
Related Concept Videos
The JAK-STAT Signaling Pathway
Co-activators and Co-repressors
TGF - β Signaling Pathway
RNA Polymerase II Accessory Proteins
PI3K/mTOR/AKT Signaling Pathway
NF-kB-dependent Signaling Pathway

